`Thymoglobulin' better than `Atgam' from every perspective

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1233, 2000-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

`Thymoglobulin' better than `Atgam' from every perspective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 258, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Economics of the Antithymocyte Globulins Thymoglobulin and Atgam in the Treatment of Acute Renal Transplant Rejection

By Schnitzler M.A.

PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. : 287-293

Adis International

Access to resources Recommend Favorite

Induction Immunosuppression in Kidney Transplant Recipients Older than 60 Years of Age: Safety and Efficacy of ATGAM®, OKT3® and Simulect®

By Michael Heifets Muhammad I. Saeed Mitten H. Parikh Debra Sierka Mysore S.A. Kumar

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 747-756

Adis International

Access to resources Recommend Favorite

Prevention is better than cure

By Borysiewicz Leszek

Clinical Medicine, Vol. 9, Iss. 6, 2009-12 ,pp. : 572-583

Royal College Of Physicians

Access to resources Recommend Favorite

Risperidone better value than olanzapine

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 261, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite